C. Puccio, M.D., and Robert G. Lerner, M.D.
Dr. Puccio is Assistant Professor of Medicine at New York Medical College in the Division of Neoplastic Disease and has published extensively on solid tumor clinical trials. Dr. Puccio reports no commercial conflict of interest. In the past three years, Dr. Lerner has served as a consultant for RPR, and has served on the Speakers' Bureau for Pharmacia & Upjohn.
Estimated course time: 1 hour(s).
Albert Einstein College of Medicine – Montefiore Medical Center designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
In support of improving patient care, this activity has been planned and implemented by Albert Einstein College of Medicine-Montefiore Medical Center and InterMDnet. Albert Einstein College of Medicine – Montefiore Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Upon completion of this Cyberounds®, you should be able to:
Discuss the controversy concerning screening for prostate cancer with prostate specific antigen
Recognize men at high risk for spinal cord compression from prostate cancer
Discuss emergency diagnostic and therapeutic management of spinal cord compression due to prostate cancer
Recognize the risk of tumor flare associated with the use of a luteinizing hormone releasing hormone agonist.
